Medications for Pituitary Acth Hypersecretion

4 results
Fresenius Kabi USA, LLC
Usage: Pantoprazole Sodium for Injection is indicated for short-term treatment of gastroesophageal reflux disease (GERD) with a history of erosive esophagitis in adults, as well as for pathological hypersecretory conditions, including Zollinger-Ellison Syndrome. Usage beyond 10 days for GERD has not been established for safety and efficacy.
Novadoz Pharmaceuticals LLC
Usage: Pantoprazole sodium for injection is indicated for short-term treatment (7 to 10 days) of gastroesophageal reflux disease (GERD) with a history of erosive esophagitis and for managing pathological hypersecretory conditions, including Zollinger-Ellison Syndrome, in adults. Long-term efficacy beyond 10 days is not established.
Recordati Rare Diseases, Inc.
Usage: SIGNIFOR is indicated for treating adult patients with Cushing's disease when pituitary surgery is not feasible or has not resulted in a cure.
Recordati Rare Diseases, Inc.
Usage: SIGNIFOR LAR is indicated for treating acromegaly in patients unresponsive to surgery or for whom surgery is not viable. Additionally, it is used for patients with Cushing's disease when pituitary surgery is not an option or has failed to cure the condition.